An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
Clinical trial NCT03157167 · COMPLETED
Trial details
- NCT number
- NCT03157167
- Sponsor
- Navidea Biopharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2019-11-05
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.